Literature DB >> 23835962

Virological monitoring of influenza activity and influenza-like illness in the epidemic season 2011-2012 in Poland.

Agnieszka Wozniak-Kosek1, Lidia B Brydak.   

Abstract

Influenza and influenza-like illnesses are recorded in all latitudes and in every age group. In Poland, the number of cases varies between several thousand and several million depending on the epidemic season. These figures are probably underestimated since a great deal of patients avoids consulting the doctor. To some extent, this situation is caused by the fear of financial loss resulting from being on sick leave. Influenza virus is classified into three types A, B, and C according to antigenic differences in their nuclear and matrix proteins. Influenza viruses are characterized by their high changeability in terms of hemagglutinin (HA) and neuraminidase (NA). The changes may be referred to as antigenic drift that consists of point mutations in the genes encoding the HA and NA or sudden changes, referred to as antigenic shift that results from an exchange of gene segments encoding hemagglutinin and neuraminidase. Since there is an animal reservoir of influenza type A virus, reassortment of different subtypes of this virus may occur with type A virus strains which occur solely in the human. This can result in the creation of an entirely new strain with hemagglutinin and/or neuraminidase subtypes which have not been encountered in humans previously, to which a large part of the population will not be resistant and which therefore has a pandemic potential. Poland participates in the Global Influenza Surveillance System for influenza and influenza-like infection throughout the year and also during the epidemic season. The main objective of supervision is a continuous monitoring of the influenza situation in the country and the most rapid detection of the emergence of a new strain of influenza virus with pandemic potential.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23835962     DOI: 10.1007/978-94-007-6627-3_12

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  2 in total

1.  Detection of respiratory tract pathogens with molecular biology methods.

Authors:  A Wozniak-Kosek; J Kosek; B Zielnik-Jurkiewicz
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

2.  Detection of Influenza and Other Respiratory Viruses Carried Out in the Influenza Project - Monitoring Vaccine Effectiveness (I-MOVE).

Authors:  Agnieszka Woźniak-Kosek
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.